About BIOwulf: Dr. Peter J. Farley

Peter J. Farley, M.D., M.B.A, President and CEO

Dr. Farley has thirty years of experience in the biotechnology industry having co-founded Cetus Corporation, the original biotechnology company, in 1971. During his fifteen (15) years at Cetus he grew the company from start-up to a 1.25 billion-dollar market valuation at the time of his retirement from Cetus. During his tenure at Cetus he directed the work of 200+ Ph.D.'s in the disciplines of molecular biology, computer science, and drug development. One of these scientists, Dr. Kary Mullis, discovered the process of Polymerase Chain Reaction (PCR) for which he was awarded the Nobel Prize in Chemistry in 1993.

Following his retirement from Cetus, Dr. Farley pursued an entrepreneurially focused career personally founding and funding start-ups spanning the fields of healthcare, E-commerce, electronics, and even a custom boat company. Dr. Farley played an active management role in each of these companies.

Dr. Farley received his M.D. degree in 1965 from St. Louis University. Following a period of surgical training, he served in the US Navy for 2 ½ years during the Vietnam era as the medical and diving officer aboard a nuclear submarine. Following his discharge from the Navy, Dr. Farley attended the Stanford University graduate school of business obtaining his MBA in 1971. He was the first physician in Stanford history to earn an MBA. Immediately upon graduation he co-founded Cetus Corporation.

Dr. Farley served as one of seven members of an advisory committee for technology and productivity to President Ronald Reagan. The committee was comprised of Silicon Valley senior executives spanning the entire high-technology spectrum. Dr. Farley represented the biotechnology /pharmaceutical industry.